First Patient Treated with OssiGraft Viable Bone Matrix

The first patient has been treated with Ossium Health’s newly-released OssiGraft viable bone matrix (VBM) allograft in an ankle surgery, representing Ossium’s entrance into the orthopedic biologics market.

Ossium’s core product is cryopreserved bone marrow derived from the vertebral columns of organ donors. This device is used in curative...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us